New pill tested to help patients with low platelets avoid dangerous bleeding
NCT ID NCT06287567
Summary
This study tested a daily pill called lusutrombopag in Chinese adults with persistent or chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, increasing bleeding risk. The goal was to see if the drug could safely raise and maintain platelet counts in patients whose previous treatments had failed. Participants took the pill for up to 12 weeks while researchers monitored their platelet levels and any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality, 300020, China
Conditions
Explore the condition pages connected to this study.